- Home
- CEPU vs AGIO Comparison
CEPU vs AGIO Comparison
Compare CEPU & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEPU | AGIO |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CEPU | AGIO |
|---|---|---|
| Price | $16.30 | $25.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $17.50 | ★ $32.13 |
| AVG Volume (30 Days) | 333.6K | ★ 2.7M |
| Earning Date | 11-11-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $607,552,200.00 | $44,791,000.00 |
| Revenue This Year | $16.07 | $28.75 |
| Revenue Next Year | $15.36 | $139.45 |
| P/E Ratio | $12.96 | ★ N/A |
| Revenue Growth | N/A | ★ 36.26 |
| 52 Week Low | $7.43 | $22.24 |
| 52 Week High | $18.50 | $46.00 |
Technical Indicators
Market Signals| Indicator | CEPU | AGIO |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 32.92 |
| Support Level | $15.67 | $26.80 |
| Resistance Level | $16.65 | $27.95 |
| Average True Range (ATR) | 0.85 | 1.03 |
| MACD | -0.19 | 0.24 |
| Stochastic Oscillator | 38.89 | 6.03 |
Price Performance
Historical ComparisonAbout CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.